Biomarkers Market
Buy Now Request Sample Explore
Home › Report Store › Life Sciences  › Biomarkers Market

Biomarkers Market Outlook: Size, Share, Trends, Growth Analysis, Competitive Landscape & Forecast, 2026-2033

The Biomarkers Market size was valued at US$ 93.91 Billion in 2025 and is projected to reach US$ 247.95 Billion by 2033, growing at a CAGR of 12.90% during 2026–2033, driven by precision medicine adoption, companion diagnostics expansion, rising chronic disease prevalence, genomic research investments, AI-enabled biomarker discovery, and increasing pharmaceutical demand for predictive and prognostic testing.

Report Coverage
  • Indication: Oncology, Cardiology, Neurology
  • End User: Pharmaceutical & Biotechnology Companies, Diagnostics & Research Laboratories, Hospitals & Specialty Clinics
US$ 93.91 Bn Market size in 2025
US$ 247.95 Bn Market Size by 2033
12.90% CAGR, 2026 - 2033
2026-2033 Forecast Period

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Biomarkers Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Biomarkers Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Biomarkers Market Global Analysis

6.2 Biomarkers Market Revenue 2022-2033 (US$ Billion)
6.3 Biomarkers Market Forecast Analysis

7. Biomarkers Market Analysis – by Indication

7.1 Oncology
  • 7.1.1 Overview
  • 7.1.2 Oncology: Biomarkers Market – Revenue and Forecast, 2022-2033 (US$ Billion)
7.2 Cardiology
  • 7.2.1 Overview
  • 7.2.2 Cardiology: Biomarkers Market – Revenue and Forecast, 2022-2033 (US$ Billion)
7.3 Neurology
  • 7.3.1 Overview
  • 7.3.2 Neurology: Biomarkers Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8. Biomarkers Market Analysis – by End User

8.1 Pharmaceutical & Biotechnology Companies
  • 8.1.1 Overview
  • 8.1.2 Pharmaceutical & Biotechnology Companies: Biomarkers Market – Revenue and Forecast, 2022-2033 (US$ Billion)
8.2 Diagnostics & Research Laboratories
  • 8.2.1 Overview
  • 8.2.2 Diagnostics & Research Laboratories: Biomarkers Market – Revenue and Forecast, 2022-2033 (US$ Billion)
8.3 Hospitals & Specialty Clinics
  • 8.3.1 Overview
  • 8.3.2 Hospitals & Specialty Clinics: Biomarkers Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9. Biomarkers Market – Geographic Analysis

9.1 Overview

9.2 North America
  • 9.2.1 Biomarkers Market Breakdown, by Key Country, 2026 and 2033 (%)
  • 9.2.1.1 Biomarkers Market – Revenue and Forecast Analysis – by Country
  • 9.2.1.1 US: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.2.1.1.1 US: Biomarkers Market Breakdown, by Indication
    • 9.2.1.1.2 US: Biomarkers Market Breakdown, by End User
  • 9.2.1.2 Canada: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.2.1.2.1 Canada: Biomarkers Market Breakdown, by Indication
    • 9.2.1.2.2 Canada: Biomarkers Market Breakdown, by End User
  • 9.2.1.3 Mexico : Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.2.1.3.1 Mexico : Biomarkers Market Breakdown, by Indication
    • 9.2.1.3.2 Mexico : Biomarkers Market Breakdown, by End User
9.3 Europe
  • 9.3.1 Biomarkers Market Breakdown, by Key Country, 2026 and 2033 (%)
  • 9.3.1.1 Biomarkers Market – Revenue and Forecast Analysis – by Country
  • 9.3.1.1 Germany: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.3.1.1.1 Germany: Biomarkers Market Breakdown, by Indication
    • 9.3.1.1.2 Germany: Biomarkers Market Breakdown, by End User
  • 9.3.1.2 Italy: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.3.1.2.1 Italy: Biomarkers Market Breakdown, by Indication
    • 9.3.1.2.2 Italy: Biomarkers Market Breakdown, by End User
  • 9.3.1.3 France: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.3.1.3.1 France: Biomarkers Market Breakdown, by Indication
    • 9.3.1.3.2 France: Biomarkers Market Breakdown, by End User
  • 9.3.1.4 U.K.: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.3.1.4.1 U.K.: Biomarkers Market Breakdown, by Indication
    • 9.3.1.4.2 U.K.: Biomarkers Market Breakdown, by End User
  • 9.3.1.5 Spain: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.3.1.5.1 Spain: Biomarkers Market Breakdown, by Indication
    • 9.3.1.5.2 Spain: Biomarkers Market Breakdown, by End User
  • 9.3.1.6 Belgium: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.3.1.6.1 Belgium: Biomarkers Market Breakdown, by Indication
    • 9.3.1.6.2 Belgium: Biomarkers Market Breakdown, by End User
  • 9.3.1.7 Netherlands: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.3.1.7.1 Netherlands: Biomarkers Market Breakdown, by Indication
    • 9.3.1.7.2 Netherlands: Biomarkers Market Breakdown, by End User
  • 9.3.1.8 Luxembourg: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.3.1.8.1 Luxembourg: Biomarkers Market Breakdown, by Indication
    • 9.3.1.8.2 Luxembourg: Biomarkers Market Breakdown, by End User
  • 9.3.1.9 Norway: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.3.1.9.1 Norway: Biomarkers Market Breakdown, by Indication
    • 9.3.1.9.2 Norway: Biomarkers Market Breakdown, by End User
  • 9.3.1.10 Finland: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.3.1.10.1 Finland: Biomarkers Market Breakdown, by Indication
    • 9.3.1.10.2 Finland: Biomarkers Market Breakdown, by End User
  • 9.3.1.11 Denmark: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.3.1.11.1 Denmark: Biomarkers Market Breakdown, by Indication
    • 9.3.1.11.2 Denmark: Biomarkers Market Breakdown, by End User
  • 9.3.1.12 Sweden: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.3.1.12.1 Sweden: Biomarkers Market Breakdown, by Indication
    • 9.3.1.12.2 Sweden: Biomarkers Market Breakdown, by End User
  • 9.3.1.13 Switzerland: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.3.1.13.1 Switzerland: Biomarkers Market Breakdown, by Indication
    • 9.3.1.13.2 Switzerland: Biomarkers Market Breakdown, by End User
  • 9.3.1.14 Austria: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.3.1.14.1 Austria: Biomarkers Market Breakdown, by Indication
    • 9.3.1.14.2 Austria: Biomarkers Market Breakdown, by End User
  • 9.3.1.15 Greece: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.3.1.15.1 Greece: Biomarkers Market Breakdown, by Indication
    • 9.3.1.15.2 Greece: Biomarkers Market Breakdown, by End User
  • 9.3.1.16 Portugal: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.3.1.16.1 Portugal: Biomarkers Market Breakdown, by Indication
    • 9.3.1.16.2 Portugal: Biomarkers Market Breakdown, by End User
  • 9.3.1.17 Russia: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.3.1.17.1 Russia: Biomarkers Market Breakdown, by Indication
    • 9.3.1.17.2 Russia: Biomarkers Market Breakdown, by End User
  • 9.3.1.18 Poland: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.3.1.18.1 Poland: Biomarkers Market Breakdown, by Indication
    • 9.3.1.18.2 Poland: Biomarkers Market Breakdown, by End User
  • 9.3.1.19 Romania: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.3.1.19.1 Romania: Biomarkers Market Breakdown, by Indication
    • 9.3.1.19.2 Romania: Biomarkers Market Breakdown, by End User
  • 9.3.1.20 Czech Republic: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.3.1.20.1 Czech Republic: Biomarkers Market Breakdown, by Indication
    • 9.3.1.20.2 Czech Republic: Biomarkers Market Breakdown, by End User
  • 9.3.1.21 Ukraine: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.3.1.21.1 Ukraine: Biomarkers Market Breakdown, by Indication
    • 9.3.1.21.2 Ukraine: Biomarkers Market Breakdown, by End User
  • 9.3.1.22 Slovakia: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.3.1.22.1 Slovakia: Biomarkers Market Breakdown, by Indication
    • 9.3.1.22.2 Slovakia: Biomarkers Market Breakdown, by End User
  • 9.3.1.23 Bulgaria : Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.3.1.23.1 Bulgaria : Biomarkers Market Breakdown, by Indication
    • 9.3.1.23.2 Bulgaria : Biomarkers Market Breakdown, by End User
9.4 Asia-Pacific
  • 9.4.1 Biomarkers Market Breakdown, by Key Country, 2026 and 2033 (%)
  • 9.4.1.1 Biomarkers Market – Revenue and Forecast Analysis – by Country
  • 9.4.1.1 China: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.4.1.1.1 China: Biomarkers Market Breakdown, by Indication
    • 9.4.1.1.2 China: Biomarkers Market Breakdown, by End User
  • 9.4.1.2 Japan: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.4.1.2.1 Japan: Biomarkers Market Breakdown, by Indication
    • 9.4.1.2.2 Japan: Biomarkers Market Breakdown, by End User
  • 9.4.1.3 South Korea: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.4.1.3.1 South Korea: Biomarkers Market Breakdown, by Indication
    • 9.4.1.3.2 South Korea: Biomarkers Market Breakdown, by End User
  • 9.4.1.4 India: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.4.1.4.1 India: Biomarkers Market Breakdown, by Indication
    • 9.4.1.4.2 India: Biomarkers Market Breakdown, by End User
  • 9.4.1.5 Australia: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.4.1.5.1 Australia: Biomarkers Market Breakdown, by Indication
    • 9.4.1.5.2 Australia: Biomarkers Market Breakdown, by End User
  • 9.4.1.6 New Zealand: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.4.1.6.1 New Zealand: Biomarkers Market Breakdown, by Indication
    • 9.4.1.6.2 New Zealand: Biomarkers Market Breakdown, by End User
  • 9.4.1.7 Indonesia: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.4.1.7.1 Indonesia: Biomarkers Market Breakdown, by Indication
    • 9.4.1.7.2 Indonesia: Biomarkers Market Breakdown, by End User
  • 9.4.1.8 Malaysia: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.4.1.8.1 Malaysia: Biomarkers Market Breakdown, by Indication
    • 9.4.1.8.2 Malaysia: Biomarkers Market Breakdown, by End User
  • 9.4.1.9 Philippines: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.4.1.9.1 Philippines: Biomarkers Market Breakdown, by Indication
    • 9.4.1.9.2 Philippines: Biomarkers Market Breakdown, by End User
  • 9.4.1.10 Singapore: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.4.1.10.1 Singapore: Biomarkers Market Breakdown, by Indication
    • 9.4.1.10.2 Singapore: Biomarkers Market Breakdown, by End User
  • 9.4.1.11 Thailand: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.4.1.11.1 Thailand: Biomarkers Market Breakdown, by Indication
    • 9.4.1.11.2 Thailand: Biomarkers Market Breakdown, by End User
  • 9.4.1.12 Vietnam: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.4.1.12.1 Vietnam: Biomarkers Market Breakdown, by Indication
    • 9.4.1.12.2 Vietnam: Biomarkers Market Breakdown, by End User
  • 9.4.1.13 Taiwan: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.4.1.13.1 Taiwan: Biomarkers Market Breakdown, by Indication
    • 9.4.1.13.2 Taiwan: Biomarkers Market Breakdown, by End User
  • 9.4.1.14 Bangladesh : Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.4.1.14.1 Bangladesh : Biomarkers Market Breakdown, by Indication
    • 9.4.1.14.2 Bangladesh : Biomarkers Market Breakdown, by End User
9.5 South and Central America
  • 9.5.1 Biomarkers Market Breakdown, by Key Country, 2026 and 2033 (%)
  • 9.5.1.1 Biomarkers Market – Revenue and Forecast Analysis – by Country
  • 9.5.1.1 Brazil: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.5.1.1.1 Brazil: Biomarkers Market Breakdown, by Indication
    • 9.5.1.1.2 Brazil: Biomarkers Market Breakdown, by End User
  • 9.5.1.2 Argentina: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.5.1.2.1 Argentina: Biomarkers Market Breakdown, by Indication
    • 9.5.1.2.2 Argentina: Biomarkers Market Breakdown, by End User
  • 9.5.1.3 Chile: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.5.1.3.1 Chile: Biomarkers Market Breakdown, by Indication
    • 9.5.1.3.2 Chile: Biomarkers Market Breakdown, by End User
  • 9.5.1.4 Colombia: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.5.1.4.1 Colombia: Biomarkers Market Breakdown, by Indication
    • 9.5.1.4.2 Colombia: Biomarkers Market Breakdown, by End User
  • 9.5.1.5 Peru : Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.5.1.5.1 Peru : Biomarkers Market Breakdown, by Indication
    • 9.5.1.5.2 Peru : Biomarkers Market Breakdown, by End User
9.6 Middle East and Africa
  • 9.6.1 Biomarkers Market Breakdown, by Key Country, 2026 and 2033 (%)
  • 9.6.1.1 Biomarkers Market – Revenue and Forecast Analysis – by Country
  • 9.6.1.1 Saudi Arabia: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.6.1.1.1 Saudi Arabia: Biomarkers Market Breakdown, by Indication
    • 9.6.1.1.2 Saudi Arabia: Biomarkers Market Breakdown, by End User
  • 9.6.1.2 United Arab Emirates: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.6.1.2.1 United Arab Emirates: Biomarkers Market Breakdown, by Indication
    • 9.6.1.2.2 United Arab Emirates: Biomarkers Market Breakdown, by End User
  • 9.6.1.3 Kuwait: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.6.1.3.1 Kuwait: Biomarkers Market Breakdown, by Indication
    • 9.6.1.3.2 Kuwait: Biomarkers Market Breakdown, by End User
  • 9.6.1.4 Bahrain: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.6.1.4.1 Bahrain: Biomarkers Market Breakdown, by Indication
    • 9.6.1.4.2 Bahrain: Biomarkers Market Breakdown, by End User
  • 9.6.1.5 Qatar: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.6.1.5.1 Qatar: Biomarkers Market Breakdown, by Indication
    • 9.6.1.5.2 Qatar: Biomarkers Market Breakdown, by End User
  • 9.6.1.6 Oman: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.6.1.6.1 Oman: Biomarkers Market Breakdown, by Indication
    • 9.6.1.6.2 Oman: Biomarkers Market Breakdown, by End User
  • 9.6.1.7 Turkiye: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.6.1.7.1 Turkiye: Biomarkers Market Breakdown, by Indication
    • 9.6.1.7.2 Turkiye: Biomarkers Market Breakdown, by End User
  • 9.6.1.8 South Africa: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.6.1.8.1 South Africa: Biomarkers Market Breakdown, by Indication
    • 9.6.1.8.2 South Africa: Biomarkers Market Breakdown, by End User
  • 9.6.1.9 Egypt: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.6.1.9.1 Egypt: Biomarkers Market Breakdown, by Indication
    • 9.6.1.9.2 Egypt: Biomarkers Market Breakdown, by End User
  • 9.6.1.10 Nigeria: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.6.1.10.1 Nigeria: Biomarkers Market Breakdown, by Indication
    • 9.6.1.10.2 Nigeria: Biomarkers Market Breakdown, by End User
  • 9.6.1.11 Algeria: Biomarkers Market – Revenue and Forecast to 2033 (US$ Billion)
    • 9.6.1.11.1 Algeria: Biomarkers Market Breakdown, by Indication
    • 9.6.1.11.2 Algeria: Biomarkers Market Breakdown, by End User

10. Competitive Landscape

10.1 Heat Map Analysis
10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments

12. Company Profiles

12.1 F. Hoffmann-La Roche Ltd.
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
12.2 Abbott Laboratories
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
12.3 Thermo Fisher Scientific Inc.
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
12.4 Bio-Rad Laboratories, Inc.
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
12.5 CENTOGENE N.V.
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
12.6 Axon Medchem B.V.
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
12.7 Sino Biological Inc.
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
12.8 R&D Systems, Inc.
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
12.9 BioVision, Inc.
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments
12.10 Myriad RBM, Inc.
  • 12.10.1 Key Facts
  • 12.10.2 Business Description
  • 12.10.3 Products and Services
  • 12.10.4 Financial Overview
  • 12.10.5 SWOT Analysis
  • 12.10.6 Key Developments
12.11 QIAGEN N.V.
  • 12.11.1 Key Facts
  • 12.11.2 Business Description
  • 12.11.3 Products and Services
  • 12.11.4 Financial Overview
  • 12.11.5 SWOT Analysis
  • 12.11.6 Key Developments
12.12 Agilent Technologies, Inc.
  • 12.12.1 Key Facts
  • 12.12.2 Business Description
  • 12.12.3 Products and Services
  • 12.12.4 Financial Overview
  • 12.12.5 SWOT Analysis
  • 12.12.6 Key Developments

13. Appendix

13.1 About Business Market Insights
13.2 List of Abbreviations

Access the Full B Market Report

Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.

Download Sample Request Customization
Access the full B Market Report
350 pages PDF & Excel | 2026-08-31
Download Sample Customization